Crossmark

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s40478-020-0891-3

Published Online: 2020-03-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lloyd, Grace M.

Trejo-Lopez, Jorge A.

Xia, Yuxing

McFarland, Karen N.

Lincoln, Sarah J.

Ertekin-Taner, Nilüfer

Giasson, Benoit I.

Yachnis, Anthony T.

Prokop, Stefan https://orcid.org/0000-0002-5633-2149
Funding

Funding for this research was provided by:

National Institute on Aging (P50 AG047266)

National Institutes of Health (RF1 AG051504, R01 AG061796, U01 AG046139)
License Information

Text and Data Mining valid from 2020-03-12

Version of Record valid from 2020-03-12
More Information

Article History

Received: 24 January 2020

Accepted: 30 January 2020

First Online: 12 March 2020

Ethics approval and consent to participate

: Staining of human tissue samples was performed with approval of the University of Florida institutional review board.

: Informed consent was obtained according to guidelines of the University of Florida institutional review board.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below